U.S. flag An official website of the United States government
  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Compliance Actions and Activities
  4. Warning Letters
  5. Colgate Palmolive Company - Close Out Letter 8/21/14
  1. Compliance Actions and Activities

CLOSEOUT LETTER

Colgate Palmolive Company 21/08/2014

Colgate Palmolive Company - Close Out Letter 8/21/14


Colgate Palmolive Company

  

Department of Health and Human Services' logoDepartment of Health and Human Services

 
 Food and Drug Administration
Silver Spring, MD 20993

 

August 21, 2014


Mr. Charles Ireland
Colgate Palmolive Company
909 River Road
Piscataway, NJ 08854


Dear Mr. Ireland,

The Food and Drug Administration has completed an evaluation of your firm’s corrective actions in response to our Warning Letter # GUDFA-14-007. Based on our evaluation, it appears that you have addressed the violations contained in this Warning Letter. Future FDA inspections or regulatory activities will further assess the adequacy and sustainability of these corrections.

This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.

 

Sincerely,

/Michael Levy/

Michael Levy
Deputy Director for Policy and Analysis
Office of Compliance
Center for Drug Evaluation and Research